Clinical Trial Update: A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 single ascending dose study in healthy participants and a multiple-dose study of JNJ-55920839 in participants …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• JNJ-55920839

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Systemic Lupus Erythematosus, Healthy | Phase 1 | Status: COMPLETED